Showing results (81-90 of 158) with videos related to
Sort By:
Pageof 16
Circulation. Cardiovascular Interventions|August 7, 2014
Association of glycemic control with mortality in patients with diabetes mellitus undergoing percutaneous coronary interventionPraneet K Sharma, Shikhar Agarwal, Stephen G Ellis, et al.Clinical Cardiology|January 31, 2014
Design and rationale of the GAUSS-2 study trial: a double-blind, ezetimibe-controlled phase 3 study of the efficacy and tolerability of evolocumab (AMG 145) in subjects with hypercholesterolemia who are intolerant of statin therapyLeslie Cho, Michael Rocco, David Colquhoun, et al.Atherosclerosis|October 7, 2016
Coronary atheroma progression rates in men and women following high-intensity statin therapy: A pooled analysis of REVERSAL, ASTEROID and SATURNBrian Stegman, Mingyuan Shao, Stephen J Nicholls, et al.The American Journal of Cardiology|September 18, 2023
Use of Coronary Artery Calcium Quantification and Distribution for Coronary Vascular Disease Risk Reclassification in a Primary Prevention SettingAdel Hajj Ali, Michael Nakhla, Leslie Cho, et al.Cardiovascular Drugs and Therapy|March 4, 2016
Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 StudyLeslie Cho, Michael Rocco, David Colquhoun, et al.Open Heart|November 24, 2021
CHA2DS2-VASc score stratifies mortality risk in patients with and without atrial fibrillationSerge C Harb, Tom Kai Ming Wang, David Nemer, et al.Inorganic Chemistry|October 29, 2010
Solid-state (15)N CPMAS NMR and computational analysis of ligand hapticity in rhodium(η-diene) poly(pyrazolyl)borate complexesRiccardo Pettinari, Claudio Pettinari, Fabio Marchetti, et al.Cardiovascular Diagnosis and Therapy|July 6, 2019
Reclassification of coronary heart disease risk in a primary prevention setting: traditional risk factor assessment vs. coronary artery calcium scoringAlaa Alashi, Richard Lang, Raul Seballos, et al.Circulation. Heart Failure|January 22, 2021
Exercise Ventricular Rates, Cardiopulmonary Exercise Performance, and Mortality in Patients With Heart Failure With Atrial FibrillationMohamed B Elshazly, Bruce L Wilkoff, Khaldoun Tarakji, et al.Journal of Clinical Lipidology|April 25, 2026
Identifying severe hypercholesterolemia in participants of ASCVD trials: Implications for trial conduct and opportunistic screeningAbhayjit Singh, Julie St John, Luke Laffin, et al.Pageof 16